CN111323382A - Identification equipment and method for prostate cancer treatment medicament - Google Patents
Identification equipment and method for prostate cancer treatment medicament Download PDFInfo
- Publication number
- CN111323382A CN111323382A CN202010210017.5A CN202010210017A CN111323382A CN 111323382 A CN111323382 A CN 111323382A CN 202010210017 A CN202010210017 A CN 202010210017A CN 111323382 A CN111323382 A CN 111323382A
- Authority
- CN
- China
- Prior art keywords
- reaction
- reaction instrument
- refrigeration
- inspection
- identification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/33—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using ultraviolet light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/82—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a precipitate or turbidity
Landscapes
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plasma & Fusion (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to the field of tumor treatment medicament equipment, and particularly relates to an identification device and method for a prostate cancer treatment medicament. The equipment facilities of a plurality of identification modes cooperate to carry out identification, and the reliability and the accuracy of identifying the proguanil used for treating the prostatic cancer treatment medicament are guaranteed in the strict identification process.
Description
Technical Field
The invention belongs to the field of tumor treatment medicament equipment, and particularly relates to identification equipment and a method for a prostate cancer medicament.
Background
Prostate cancer refers to an epithelial malignancy that occurs in the prostate. The pathological types of the prostate cancer in the WHO in 2004, the pathological types of the tumors of the urinary system and the male genital organs, comprise adenocarcinoma (acinar adenocarcinoma), ductal adenocarcinoma, urothelial carcinoma, squamous cell carcinoma and adenosquamous carcinoma. Among them, prostatic adenocarcinoma accounts for 95% or more, and therefore, the term "prostatic cancer" is generally used to refer to prostatic adenocarcinoma. The incidence rate of prostate cancer in the tumor registration area of China in 2012 is 9.92/10 ten thousand, which is the 6 th of the incidence rate of malignant tumors in men. The onset age is at a low level before 55 years, the onset gradually increases after 55 years, the incidence rate increases with the increase of the age, and the peak age is 70-80 years. The family hereditary prostate cancer patients are early in onset age, patients with age less than or equal to 55 years are 43 percent, the existing medicaments for treating the prostate cancer, such as adriamycin, mitomycin, cisplatin, fluorouracil, estramustine phosphate and the like, have unstable treatment effect, great toxic and side effects and limited adaptability, and the proguanil is a medicament with stable performance for treating the prostate cancer and has low toxicity, but the existing proguanil lacks integrated equipment for systematic simple and reliable identification, and seriously restricts the development and popularization research of the proguanil in the direction of the prostate cancer.
Disclosure of Invention
In order to solve one of the background technical problems, the invention provides an identification device for a prostate cancer treatment medicament, which comprises an identification body, a reaction instrument, an inspection facility and a verification mechanism, wherein the inspection facility is arranged at one end of the identification body, the reaction instrument is arranged in an inspection groove arranged in the inspection facility, the verification mechanism is arranged at the other end of the identification body, and a refrigeration reaction instrument bin is arranged in the verification mechanism so as to realize identification of the prostate cancer treatment medicament.
Preferably, it is the loudspeaker type to test the identification body, the big oral area of loudspeaker type is divided and is set up reaction instrument, inspection facility and verification mechanism, the bellmouth upper portion surface of loudspeaker type is operation platform, the little oral area of loudspeaker type divide into the support part and the refrigerating unit part that refrigeration reaction instrument storehouse matches.
Preferably, the reaction instrument constitutes including premixing reaction zone, self-sealing nature and reaction verification district, premixing reaction zone sets up to trapezoidal structure, and the bottom of trapezoidal structure is connected through self-sealing nature and is sealed, self-sealing nature stops the district including self-sealing mechanism, self-sealing mechanism and constitutes, self-sealing nature lower part sets up the reaction and verifies the district, the reaction is verified the district and is made for square column transparent material.
Preferably, the automatic closing mechanism includes the elasticity closing cap, closing cap one end adhesion in on the premixing reaction zone lower extreme lateral wall, the adhesion is provided with the spring of automatic rebound closing cap around the closing cap of reaction zone lower extreme lateral wall simultaneously, the big or small closing cap of closing cap the terminal surface of reaction zone lower extreme, the automatic closing mechanism stay district set up in premixing reaction zone with between the reaction verification district, and to the outside slope protrusion of reaction instrument to make the elasticity closing cap stay in the automatic closing mechanism stay district at the rotatory in-process of opening downwards.
Preferably, the reaction instrument constitutes still including digital display stirring pressure filter rod, the stirring is pressed filter rod and is become including triangle clamp plate, connecting rod, digital display manometer, the one corner and the connecting rod of triangle clamp plate are connected, the connecting rod is connected with the digital display manometer, the pressure face width of triangle clamp plate matches with the internal diameter of the square column in reaction identification district in order to realize to mix in advance the reaction area and get into and carry out the filter-pressing in the square column in reaction identification district.
Preferably, the inspection facility comprises an ultraviolet lamp, an optical filter, an inspection groove, a condenser and a photoelectric detector, wherein the optical filter, the inspection groove, the condenser and the photoelectric detector are arranged along the irradiation direction of the ultraviolet lamp in sequence according to an optical route so as to realize the inspection of substances in a reaction instrument in the inspection groove.
Preferably, the refrigeration reaction instrument bin in the verification mechanism comprises a U-shaped structure design, a cooling area and a heat preservation layer are sequentially arranged on the periphery of the U-shaped structure, a movable sealing cover is arranged on the upper portion of the cooling area, and cooling substances can be added into the cooling area through the movable sealing cover so as to realize refrigeration and constant temperature of the refrigeration reaction instrument in the U-shaped bin.
Preferably, still including establishing the refrigeration pipeline in the cooling zone, the refrigeration pipeline sets up and constructs two surveys at U type, the refrigeration pipeline connects the setting of the loudspeaker osculum support part bottom of loudspeaker type the refrigerating unit part is connected the refrigerating unit through the refrigeration pipeline and is realized refrigerating constant temperature in the refrigeration reaction instrument storehouse.
Preferably, one side of the verification mechanism arranged in the verification body is also provided with a filter-pressing quantitative mechanism of a reaction instrument, the filter-pressing quantitative mechanism is fixed through a conical fixing frame arranged on one side of the verification mechanism, the reaction instrument of the filter screen is arranged at the fixed lower end of the upper end of the fixing frame, the lower end of the fixing frame is communicated with a liquid discharge switch, the reaction instrument is provided with a digital display stirring pressure filter stick, and the reaction instrument is provided with a scale for measuring the identified medicament so as to measure the quality of the identified medicament.
Adding hot water at 50 ℃ into a reaction instrument in a detection tank, then adding 0.1 mol of hot water to obtain a prostate cancer treatment agent proguanil and 0.1 mol of ammoniated copper sulfate, stirring and dissolving by using a digital display stirring and pressing filter stick to form a proguanil solution at a temperature of not less than 20 ℃, pressing by using a digital display stirring and pressing filter stick to open an elastic sealing cover so that the proguanil solution flows into a transparent square column in a reaction detection area, supplementing hot water to 2/3 of the volume of the transparent square column, and uniformly stirring by using a stirring and pressing filter stick to form a proguanil primary identification solution at a temperature of not less than 15 ℃; starting an inspection facility, irradiating the chloroguanidine primary identification solution by ultraviolet light with the wavelength of the ultraviolet lamp at 260-280nm, testing the absorbance of the chloroguanidine primary identification solution by a photoelectric detector, and when the absorbance is not more than 0.04, primarily identifying the chloroguanidine primary identification solution as a prostate cancer treatment medicament, and then carrying out the next step; and secondly, placing the reaction instrument filled with the primarily identified proguanil solution in the first step into a U-shaped bin of a verification mechanism, adding a cooling substance into a cooling area or refrigerating by using a refrigerating pipeline to realize that the refrigerating temperature of the refrigerating reaction instrument in the U-shaped bin is 10 ℃, observing whether the primarily identified proguanil solution has precipitation or not, and identifying the proguanil as a prostate cancer treatment medicament proguanil if the precipitation occurs.
The beneficial effects of the invention include: the equipment can systematically and reliably identify the proguanil for treating the prostatic cancer treatment medicament, the identification equipment is integrally arranged, the identification is carried out by the cooperation of equipment facilities in a plurality of identification modes, and the reliability and the accuracy of identifying the proguanil for treating the prostatic cancer treatment medicament are guaranteed in the strict identification process. The equipment of the invention has simple and rigorous structure, and the flow operation is simple and easy to master, thus the equipment is a practical and popularized identification device for the proguanil of the prostatic cancer treatment medicament, and has wide significance for popularization and deep development of the proguanil of the prostatic cancer treatment medicament in the field of tumor treatment.
Drawings
FIG. 1: the overall structure of the device is schematic;
FIG. 2: the structure of the verification mechanism part in the device is shown schematically;
FIG. 3: the structure of the reaction apparatus part of the apparatus of the present invention is schematically shown.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
As shown in fig. 1-3, an equipment for identifying a prostate cancer therapeutic agent comprises an identification body 1, a reaction device 2, an inspection facility 3 and a verification mechanism 5, wherein the inspection facility 3 is arranged at one end of the identification body 1, the reaction device 2 is arranged in an inspection groove 31 arranged in the inspection facility to facilitate preliminary inspection and identification, the verification mechanism 5 is arranged at the other end of the identification body 1, and a refrigeration reaction device chamber 51 is arranged in the verification mechanism 5 to realize identification of the prostate cancer therapeutic agent.
The inspection body is the horn type, the big oral area of loudspeaker of horn type divides and sets up reaction instrument, inspection facility and verification mechanism, the horn mouth upper portion surface of horn type is operation platform, the little oral area of loudspeaker of horn type divide into the support part and reach refrigeration unit part that refrigeration reaction instrument storehouse matches.
As shown in fig. 3, the reaction instrument constitutes including premixing reaction zone 21, self-sealing region 22 and reaction verification district 23, premixing reaction zone 21 sets up to trapezoidal structure, and the bottom of trapezoidal structure is connected through self-sealing region and is sealed to realize the premixed reaction, self-sealing region 22 includes that self-sealing mechanism, self-sealing mechanism stay district 223 constitute, self-sealing region lower part sets up reaction verification district 23, reaction verification district 23 is made for square column transparent material.
The automatic closing mechanism comprises an elastic closing cover 221, one end of the closing cover is adhered to the side wall of the lower end of the premixing reaction zone, and meanwhile springs 222 for automatically rebounding to close the closing cover are arranged around the closing cover of the side wall of the lower end of the reaction zone in an adhesion mode, the closing cover is sealed at the size of the closing cover, the end face of the lower end of the reaction zone is sealed at the end face of the lower end of the reaction zone, and the automatic closing mechanism stopping zone is arranged between the premixing reaction zone and the reaction verification zone and protrudes towards the outside of the reaction instrument in an inclined mode, so that the elastic closing cover stops in the automatic closing mechanism stopping zone 223 in the.
The reactor constitutes still including digital display stirring pressure filter rod 24, what filter rod 24 was pressed in the stirring includes triangle clamp plate 241, connecting rod, digital display manometer constitution, the one corner and the connecting rod of triangle clamp plate are connected, the connecting rod is connected with the digital display manometer, the pressure face width of triangle clamp plate matches with the internal diameter of the square column of reaction identification district in order to realize to mix the reaction zone in advance and get into and carry out the filter-pressing in the square column of reaction identification district.
The inspection facility 3 comprises an ultraviolet lamp 32, a filter 33, an inspection tank 31, a condenser 34 and a photoelectric detector 35, wherein the filter 33, the inspection tank 31, the condenser 34 and the photoelectric detector 35 are sequentially arranged along the irradiation direction of the ultraviolet lamp according to an optical path so as to realize the inspection of substances in reaction instruments in the inspection tank.
As shown in fig. 2, the refrigeration reaction instrument bin 51 in the verification mechanism includes a "U" shaped structure design, a cooling area 511 and a heat preservation layer 512 are sequentially arranged around the U-shaped structure, a movable sealing cover 513 is arranged on the upper portion of the cooling area, and a cooling substance, such as an ice block, can be added into the cooling area through the movable sealing cover, so as to realize refrigeration and constant temperature of the refrigeration reaction instrument in the U-shaped bin.
Still including establishing refrigeration pipeline 5111 in the cooling zone, refrigeration pipeline 5111 sets up two surveys at U type structure, the setting of the horn osculum support part bottom of refrigeration pipe connection loudspeaker type refrigerating unit 514 part, preferred the liquid cooling system that the preferred semiconductor refrigeration piece of refrigerating unit 514 constitutes, through refrigeration pipe connection refrigerating unit realize 514 constant temperature to refrigerating in the refrigeration reaction instrument storehouse.
The identification device is characterized in that a filter-pressing quantitative mechanism 4 of a reaction instrument is further arranged on one side of the identification mechanism, the filter-pressing quantitative mechanism is fixed 41 through a conical fixing frame arranged on one side of the identification mechanism, the reaction instrument of the screen 25 is arranged at the fixed lower end of the upper end of the fixing frame, the lower end of the fixing frame is communicated with a liquid drainage switch, the reaction instrument is provided with a digital display stirring pressure filter stick, a graduated scale for measuring an identified medicament is arranged on the reaction instrument, and the graduated scale is calibrated through precipitates corresponding to the graduated scale so as to measure the quality of the identified medicament.
The method for identifying the prostatic cancer treatment medicament, namely the proguanil, by the aid of the identification device is described as follows, principle and process and beneficial effects of the method are described, specifically, the method for identifying the prostatic cancer treatment medicament by the identification device comprises the steps that firstly, hot water at 50 ℃ is added into a reaction instrument in an inspection tank, then 0.1 mole of hot water is added to obtain the identified prostatic cancer treatment medicament, namely the proguanil and 0.1 mole of ammonia prepared copper sulfate, a digital display stirring and pressing filter stick is used for stirring and dissolving to form a proguanil solution at the temperature of not less than 20 ℃, an elastic sealing cover is pressed and opened by the digital display stirring and pressing filter stick to enable the proguanil solution to flow into a transparent square column in a reaction inspection area, the hot water is added to 2/3 of the volume of the transparent square column, and the mixture is uniformly stirred by the stirring and pressing; starting an inspection facility, irradiating the chloroguanidine primary identification solution by ultraviolet light with the wavelength of the ultraviolet lamp at 260-280nm, testing the absorbance of the chloroguanidine primary identification solution by a photoelectric detector, and when the absorbance is not more than 0.04g/L, primarily identifying the chloroguanidine primary identification solution as a prostate cancer treatment medicament, and then carrying out the next step; and secondly, placing the reaction instrument filled with the primarily identified proguanil solution in the first step into a U-shaped bin of a verification mechanism, adding a cooling substance into a cooling area or refrigerating by using a refrigerating pipeline to realize that the refrigerating temperature of the refrigerating reaction instrument in the U-shaped bin is 10 ℃, observing whether the primarily identified proguanil solution has precipitation or not, and identifying the proguanil as a prostate cancer treatment medicament proguanil if the precipitation occurs.
Further, pouring the prostate cancer treatment medicament proguanil precipitate identified in the second step into an analysis instrument on a conical fixing frame in the filter-pressing quantifying mechanism, performing filter-pressing by using a digital display stirring and pressing filter stick, and measuring the quality of the identified medicament by using a graduated scale arranged on a reaction instrument.
The equipment facilities in multiple identification modes cooperate to carry out identification, and the reliability and accuracy of identifying the proguanil for treating the prostatic cancer treatment medicament are ensured by the strict identification process.
The above-mentioned embodiments are merely illustrative of the preferred embodiments of the present invention, and do not limit the scope of the present invention, and various modifications and improvements made to the technical solution of the present invention by those skilled in the art without departing from the spirit of the present invention shall fall within the protection scope defined by the claims of the present invention.
Claims (10)
1. An identification device for a prostate cancer treatment agent, characterized in that: constitute including verifying body, reaction instrument, inspection facility, accreditation mechanism, the inspection facility set up in the one end of verifying the prison body, the reaction instrument set up in the inspection groove that sets up in the inspection facility, accreditation mechanism sets up the other end of verifying the body, be provided with refrigeration reaction instrument storehouse in the accreditation mechanism to the realization is to the differentiation of prostatic cancer treatment agent.
2. The authentication apparatus of claim 1, wherein: the inspection body is the horn type, the big oral area of loudspeaker of horn type divides and sets up reaction instrument, inspection facility and verification mechanism, the horn mouth upper portion surface of horn type is operation platform, the little oral area of loudspeaker of horn type divide into the support part and reach refrigeration unit part that refrigeration reaction instrument storehouse matches.
3. The authentication apparatus of claim 2, wherein: the reaction instrument constitutes including mixing reaction zone, self-sealing nature and reaction and testing the district in advance, mix the reaction zone in advance and set up to trapezoidal structure, the bottom of trapezoidal structure is connected through self-sealing nature and is sealed, self-sealing nature includes that self-sealing mechanism, self-sealing mechanism stop the district and constitute, self-sealing nature lower part sets up the reaction and tests the district, the reaction is tested the district and is made for square column transparent material.
4. The authentication apparatus of claim 3, wherein: the automatic closing mechanism comprises an elastic closing cover, one end of the closing cover is adhered to the side wall of the lower end of the premixing reaction zone, and springs for automatically rebounding the closing cover are arranged around the closing cover of the side wall of the lower end of the reaction zone in an adhesion mode.
5. The authentication apparatus of claim 4, wherein: the reactor constitutes still including digital display stirring pressure filter rod, the filter rod is pressed in the stirring includes triangle-shaped clamp plate, connecting rod, digital display manometer constitution, the one corner and the connecting rod of triangle-shaped clamp plate are connected, the connecting rod is connected with the digital display manometer, the pressure face width of triangle-shaped clamp plate matches with the internal diameter of the square column of reaction identification district in order to realize to mix the reaction area in advance and get into and carry out the filter-pressing in the square column of reaction identification district.
6. The authentication apparatus of claim 5, wherein: the inspection facility comprises an ultraviolet lamp, an optical filter, an inspection groove, a condensing lens and a photoelectric detector, and the optical filter, the inspection groove, the condensing lens and the photoelectric detector are sequentially arranged along the irradiation direction of the ultraviolet lamp according to an optical route so as to realize the inspection of substances in a reaction instrument in the inspection groove.
7. The authentication apparatus of claim 6, wherein: the refrigeration reaction instrument bin in the verification mechanism comprises a U-shaped structure design, a cooling area and a heat preservation layer are sequentially arranged on the periphery of the U-shaped structure, a movable sealing cover is arranged on the upper portion of the cooling area, and cooling substances can be added into the cooling area through the movable sealing cover so as to realize refrigeration and constant temperature of the refrigeration reaction instrument in the U-shaped bin.
8. The authentication apparatus of claim 7, wherein: still including establishing the refrigeration pipeline in the cooling zone, the refrigeration pipeline sets up and constructs two surveys at U type, the setting of the small-mouth support portion bottom of the loudspeaker of refrigeration pipeline connection loudspeaker type the refrigerating unit part is realized refrigerating constant temperature in the refrigeration reaction instrument storehouse through refrigeration pipeline connection refrigerating unit.
9. The authentication apparatus of claim 8, wherein: the device comprises an identification body, a verification mechanism and a liquid discharge switch, wherein a pressure filtration quantifying mechanism of a reaction instrument is further arranged on one side of the verification mechanism and is fixed through a conical fixing frame arranged on one side of the verification mechanism, the reaction instrument allowing for a net is arranged at the fixed lower end of the upper end of the fixing frame, the lower end of the fixing frame is communicated with the liquid discharge switch, the reaction instrument is provided with a digital display stirring pressure filter stick, and a graduated scale for measuring the quality of the identified medicament is arranged on the reaction instrument so as to measure the quality of the identified medicament.
10. The method for identifying a prostate cancer therapeutic agent by the identification device according to any one of claims 1 to 9, wherein: comprises the first step, adding 50 ℃ hot water into a reaction instrument in an inspection groove, then adding 0.1 mol of hot water to obtain the identified prostatic cancer treatment medicament of proguanil and 0.1 mol of ammonia copper sulfate, stirring and dissolving by a digital display stirring and pressing filter stick to form a proguanil solution with the temperature of no less than 20 ℃, pressing by the digital display stirring and pressing filter stick to open an elastic sealing cover to enable the proguanil solution to flow into a transparent square column in a reaction inspection area, adding hot water to 2/3 of the volume of the transparent square column, uniformly stirring by using a stirring and pressing filter stick to form a chloroguanidine primary identification solution with the temperature of not lower than 15 ℃, starting an inspection facility, irradiating the chloroguanidine primary identification solution by using ultraviolet light with the wavelength of an ultraviolet lamp at 260-280nm, testing the absorbance of the chloroguanidine primary identification solution by using a photoelectric detector, when the absorbance is not more than 0.04, the prostate cancer treatment drug is primarily identified, and then the next step is carried out; and secondly, placing the reaction instrument filled with the primarily identified proguanil solution in the first step into a U-shaped bin of a verification mechanism, adding a cooling substance into a cooling area or refrigerating by using a refrigerating pipeline to realize that the refrigerating temperature of the refrigerating reaction instrument in the U-shaped bin is 10 ℃, observing whether the primarily identified proguanil solution has precipitation or not, and identifying the proguanil as a prostate cancer treatment medicament proguanil if the precipitation occurs.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010210017.5A CN111323382B (en) | 2020-03-23 | 2020-03-23 | Identification equipment and method for prostate cancer treatment medicament |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010210017.5A CN111323382B (en) | 2020-03-23 | 2020-03-23 | Identification equipment and method for prostate cancer treatment medicament |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111323382A true CN111323382A (en) | 2020-06-23 |
| CN111323382B CN111323382B (en) | 2023-03-14 |
Family
ID=71171757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010210017.5A Active CN111323382B (en) | 2020-03-23 | 2020-03-23 | Identification equipment and method for prostate cancer treatment medicament |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111323382B (en) |
Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1084728A (en) * | 1977-04-14 | 1980-09-02 | Rodolfo R. Rodriguez | Modular chemical analysis system |
| WO1994003774A1 (en) * | 1992-07-31 | 1994-02-17 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US5566086A (en) * | 1993-03-01 | 1996-10-15 | Doyle; Walter M. | Method of ensuring accurate identification and measurement of solutes |
| US20020048610A1 (en) * | 2000-01-07 | 2002-04-25 | Cima Michael J. | High-throughput formation, identification, and analysis of diverse solid-forms |
| US20030119060A1 (en) * | 2001-08-10 | 2003-06-26 | Desrosiers Peter J. | Apparatuses and methods for creating and testing pre-formulations and systems for same |
| CN101339178A (en) * | 2008-08-07 | 2009-01-07 | 贵州天安药业股份有限公司 | Metformin hydrochloride enteric-coated tablets quality control method |
| US20100291669A1 (en) * | 2009-05-15 | 2010-11-18 | Biomerieux, Inc. | System for rapid identification and/or characterization of a microbial agent in a sample |
| US20100288944A1 (en) * | 2008-01-04 | 2010-11-18 | Pion, Inc. | Methods and systems for in situ physicochemical property testing |
| US20110255745A1 (en) * | 2008-11-14 | 2011-10-20 | The Scripps Research Institute | Image analysis platform for identifying artifacts in samples and laboratory consumables |
| US20130265568A1 (en) * | 2012-03-27 | 2013-10-10 | Innovative Science Tools, Inc. | Optical analyzer for identification of materials using transmission spectroscopy |
| CN205449804U (en) * | 2016-03-30 | 2016-08-10 | 李莉 | Chinese -medicinal material detection and identification device |
| CN207318478U (en) * | 2017-09-29 | 2018-05-04 | 耿书军 | Portable medicine differentiates case |
-
2020
- 2020-03-23 CN CN202010210017.5A patent/CN111323382B/en active Active
Patent Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1084728A (en) * | 1977-04-14 | 1980-09-02 | Rodolfo R. Rodriguez | Modular chemical analysis system |
| WO1994003774A1 (en) * | 1992-07-31 | 1994-02-17 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US5566086A (en) * | 1993-03-01 | 1996-10-15 | Doyle; Walter M. | Method of ensuring accurate identification and measurement of solutes |
| US20020048610A1 (en) * | 2000-01-07 | 2002-04-25 | Cima Michael J. | High-throughput formation, identification, and analysis of diverse solid-forms |
| US20030119060A1 (en) * | 2001-08-10 | 2003-06-26 | Desrosiers Peter J. | Apparatuses and methods for creating and testing pre-formulations and systems for same |
| US20100288944A1 (en) * | 2008-01-04 | 2010-11-18 | Pion, Inc. | Methods and systems for in situ physicochemical property testing |
| CN101339178A (en) * | 2008-08-07 | 2009-01-07 | 贵州天安药业股份有限公司 | Metformin hydrochloride enteric-coated tablets quality control method |
| US20110255745A1 (en) * | 2008-11-14 | 2011-10-20 | The Scripps Research Institute | Image analysis platform for identifying artifacts in samples and laboratory consumables |
| US20100291669A1 (en) * | 2009-05-15 | 2010-11-18 | Biomerieux, Inc. | System for rapid identification and/or characterization of a microbial agent in a sample |
| US20130265568A1 (en) * | 2012-03-27 | 2013-10-10 | Innovative Science Tools, Inc. | Optical analyzer for identification of materials using transmission spectroscopy |
| CN205449804U (en) * | 2016-03-30 | 2016-08-10 | 李莉 | Chinese -medicinal material detection and identification device |
| CN207318478U (en) * | 2017-09-29 | 2018-05-04 | 耿书军 | Portable medicine differentiates case |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111323382B (en) | 2023-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3713328A (en) | Automatic measurement of viscosity | |
| CN108686721A (en) | Micro-fluidic chip and its detection method for whole blood sample separation detection | |
| CN103529207A (en) | Combined device for rapidly and quantitatively detecting multiple tumor markers | |
| CN111323382B (en) | Identification equipment and method for prostate cancer treatment medicament | |
| CN106198327A (en) | A kind of liquid particles detection device | |
| CN110456077A (en) | A method of the immunomagnetic beads enrichment detection CTCs of coupling anti-EpCAM antibody | |
| Zhang et al. | Disease‐specific IgG Fc glycosylation ratios as personalized biomarkers to differentiate non‐small cell lung cancer from benign lung diseases | |
| WO2021213290A1 (en) | Kit for testing expression of ca199 in circulating tumor cells in peripheral blood of patients with pancreatic cancer and testing method | |
| CN103048468A (en) | Rapid detecting method for determining targeting therapy medicaments of tumors | |
| CN111521793A (en) | Immunofluorescence kit and detection method for detecting CEA gene mutation in peripheral blood circulating tumor cells of patients with non-small cell lung cancer | |
| CN116086919B (en) | Staining method and kit for lung cancer and/or pancreatic cancer samples | |
| CN111521792A (en) | Immunofluorescence kit and method for detecting PD-L1 gene mutation in peripheral blood circulating tumor cells of patients with non-small cell lung cancer | |
| WO2021213257A1 (en) | Detection and identification method for circulating tumor cells (ctcs) | |
| CN111521801A (en) | Kit for detecting the expression of BRAF gene V600E mutation in patients with colorectal cancer by circulating tumor cells in peripheral blood | |
| CN207703711U (en) | A kind of sealing gas circuit switch sampling device for Testing Mercury by cold Atom Absorphotometry instrument | |
| CN109752539A (en) | A kind of melanoma tumors cell joint quantitative test card and preparation method thereof and application method | |
| CN111929122B (en) | Antigen repairing method for immunocytochemical staining, cell suspension and chemical staining method using same | |
| CN103499691A (en) | Detection test paper of HER2 protein expression level | |
| CN218212630U (en) | Circulating tumor cell malaria protein detection device | |
| CN210221777U (en) | Combined detection card for immunoassay and cell analysis | |
| CN111534586A (en) | Kit and method for detecting CEA gene mutation of peripheral blood circulating tumor cells of non-small cell lung cancer patients | |
| CN111638355A (en) | Kit and method for detecting expression of circulating tumor cells E-Cadherin in peripheral blood of breast cancer patient | |
| CN110907647A (en) | New uses of the CLEC5A gene | |
| CN111596056A (en) | Kit and method for detecting prostate cancer patient peripheral blood circulating tumor cell PD-L1 gene mutation | |
| CN220772867U (en) | Multifunctional comprehensive water permeability testing device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Jia Lizhou Inventor after: Tang Genxiong Inventor after: Yang Zhiping Inventor before: Yang Zhiping Inventor before: Tang Genxiong Inventor before: Jia Lizhou |